Products
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
Osteokare

Antibotics

CEFO L 100 DT
Description
Cefixime is a broad spectrum III Gen Cephalosporin Antibiotic. Excellent clinical efficacy has been observed in several indications like respiratory tract infections, urinary tract infection and enteric fever. But its use is associated with diarrhea in 15-20% of patients which makes treatment complicated. Lactobacillus is a probiotic, which help to re-establish the normal conditions in the colon and prevent antibiotic induced diarrhoea. The combination provides excellent efficacy against various infection caused by gram–ve and gram +ve bacteria without alteration in the normal microbial ecosystem of intestine.
Indications

Respiratory Tract Infection
Ear Infection

Urinary Tract Infection
Enteric Fever

Composition
Each Dispersible tablet contains
 

Cefixime trihydrate
100mg

Lactobacillus
60 million spores

Dosage
Adults
200 mg twice a day

Children
8 mg/kg/day in divided doses (b.i.d)

UTI & RTI
5-7 days

Enteric Fever
7-14 days

Side Effects

Rare side effects like diarrhoea, nausea, abdominal pain, stool changes, headache, and dizziness


Precautions
Pregnancy
Not enough studies to document use in pregnancy.

Nursing Mothers
It is not known whether CEFIXIME is secreted in human milk or not.

Paediatric Use
Safety and effectiveness not established in infants (less than six months old)

Presentation
CEFO L 100 DT is available as a strip of 10 tablets
CEFO L 200 DT
Description
Cefixime is a broad spectrum III Gen Cephalosporin Antibiotic. Excellent clinical efficacy has been observed in several indications like respiratory tract infections, urinary tract infection and enteric fever. But its use is associated with diarrhea in 15-20% of patients which makes treatment complicated. Lactobacillus is a probiotic, which help to re-establish the normal conditions in the colon and prevent antibiotic induced diarrhoea. The combination provides excellent efficacy against various infection caused by gram–ve and gram +ve bacteria without alteration in the normal microbial ecosystem of intestine.
Indications

Respiratory Tract Infection
Ear Infection

Urinary Tract Infection
Enteric Fever

Composition
Each Dispersible tablet contains
 

Cefixime trihydrate
200mg

Lactobacillus
60 million spores

Dosage
Adults
200 mg twice a day

Children
8 mg/kg/day in divided doses (b.i.d)

UTI & RTI
5-7 days

Enteric Fever
7-14 days

Side Effects

Rare side effects like diarrhoea, nausea, abdominal pain, stool changes, headache, and dizziness


Precautions
Pregnancy
Not enough studies to document use in pregnancy.

Nursing Mothers
It is not known whether CEFIXIME is secreted in human milk or not.

Paediatric Use
Safety and effectiveness not established in infants (less than six months old)

Presentation
CEFO L 200 DT is available as a strip of 10 tablets
CEFO L 50 DT
Description
Cefixime is a broad spectrum III Gen Cephalosporin Antibiotic. Excellent clinical efficacy has been observed in several indications like respiratory tract infections, urinary tract infection and enteric fever. But its use is associated with diarrhea in 15-20% of patients which makes treatment complicated. Lactobacillus is a probiotic, which help to re-establish the normal conditions in the colon and prevent antibiotic induced diarrhoea. The combination provides excellent efficacy against various infection caused by gram–ve and gram +ve bacteria without alteration in the normal microbial ecosystem of intestine.
Indications

Respiratory Tract Infection
Ear Infection

Urinary Tract Infection
Enteric Fever

Composition
Each Dispersible tablet contains
 

Cefixime trihydrate
50mg

Lactobacillus
60 million spores

Dosage
Adults
200 mg twice a day

Children
8 mg/kg/day in divided doses (b.i.d)

UTI & RTI
5-7 days

Enteric Fever
7-14 days

Side Effects

Rare side effects like diarrhoea, nausea, abdominal pain, stool changes, headache, and dizziness


Precautions
Pregnancy
Not enough studies to document use in pregnancy.

Nursing Mothers
It is not known whether CEFIXIME is secreted in human milk or not.

Paediatric Use
Safety and effectiveness not established in infants (less than six months old)

Presentation
CEFO L 50 DT is available as a strip of 10 tablets
CEFO L SUSPN
Description
Cefixime is a broad spectrum III Gen Cephalosporin Antibiotic. Excellent clinical efficacy has been observed in several indications like respiratory tract infections, urinary tract infection and enteric fever. But its use is associated with diarrhea in 15-20% of patients which makes treatment complicated. Lactobacillus is a probiotic, which help to re-establish the normal conditions in the colon and prevent antibiotic induced diarrhoea. The combination provides excellent efficacy against various infection caused by gram–ve and gram +ve bacteria without alteration in the normal microbial ecosystem of intestine.
Indications

Respiratory Tract Infection
Ear Infection

Urinary Tract Infection
Enteric Fever

Composition
Each 5ml contains
 

Cefixime trihydrate USP equivalent to Cefixime
50mg

Lactic Acid Bacillus
60 million spores

Dosage
1 teaspoonful twice daily
 

Side Effects

Rare side effects like diarrhoea, nausea, abdominal pain, stool changes, headache, and dizziness


Precautions
Pregnancy
Not enough studies to document use in pregnancy.

Nursing Mothers
It is not known whether CEFIXIME is secreted in human milk or not.

Paediatric Use
Safety and effectiveness not established in infants (less than six months old)

Presentation
CEFO L SUSPN is available as a strip of 10 tablets
TAZOCEF 0.2812
Description
Ceftriaxone IIIrd generation cephalosporins. Tazobactam the inhibitors of variety of plasma mediated b-lactamases. Ceftriaxone in combination with Tazobactam given in one dose immediately after infection shows a significant reduction in bacterial count.


Indications
Lower respiratory tract infections, Nosocomial infections, and surgical prophylaxis
Meningitis, Skin and soft tissue infection like cellulitis. Chronic suppurative bacterial Otitis media, Bone & Joint infections, Sexually transmitted disease (gonorrhea, syphilis), Urinary tract infections (complicated by underlying urological abnormalities).
Composition
Each Vial contains:
 

Ceftriaxone
250 mg

Tazobactam
31.25 mg

Dosage
The usual daily dose is 1-2 gm given once a day. Total daily dose should not exceed 4gms.
Pediatric Patients: Recommended total daily dose (in terms of ceftriaxone) 50 to 75 mg / kg given once in a day (or in equally divided doses twice a day). The total daily dose not to exceed 1gm.
Side Effects
GI effects 2 to 3%, cutaneous reactions 1-3%, hematologicals 1-2% Miscellaneous 1.5 to 3%. Rarely, acute anaphylaxis to any of the drug may occur in susceptible individuals.
Precautions
Pregnancy: not advisable for the use
Nursing Mother: caution to exercise.
Pediatric Use: Not to be recommended to hyper bilirubinemic neonates, especially premature.
Presentation
TAZOCEF 0.2812 is available as a strip of 10 tablets
TAZOCEF 0.5625
Description
Ceftriaxone IIIrd generation cephalosporins. Tazobactam the inhibitors of variety of plasma mediated b-lactamases. Ceftriaxone in combination with Tazobactam given in one dose immediately after infection shows a significant reduction in bacterial count.


Indications
Lower respiratory tract infections, Nosocomial infections, and surgical prophylaxis
Meningitis, Skin and soft tissue infection like cellulitis. Chronic suppurative bacterial Otitis media, Bone & Joint infections, Sexually transmitted disease (gonorrhea, syphilis), Urinary tract infections (complicated by underlying urological abnormalities).
Composition
Each Vial contains:
 

Ceftriaxone
500 mg

Tazobactam
62.5 mg

Dosage
The usual daily dose is 1-2 gm given once a day. Total daily dose should not exceed 4gms.
Pediatric Patients: Recommended total daily dose (in terms of ceftriaxone) 50 to 75 mg / kg given once in a day (or in equally divided doses twice a day). The total daily dose not to exceed 1gm.
Side Effects
GI effects 2 to 3%, cutaneous reactions 1-3%, hematologicals 1-2% Miscellaneous 1.5 to 3%. Rarely, acute anaphylaxis to any of the drug may occur in susceptible individuals.
Precautions
Pregnancy: not advisable for the use
Nursing Mother: caution to exercise.
Pediatric Use: Not to be recommended to hyper bilirubinemic neonates, especially premature.
Presentation
TAZOCEF 0.5625 is available as a strip of 10 tablets
TAZOCEF 1.125
Description
Ceftriaxone IIIrd generation cephalosporins. Tazobactam the inhibitors of variety of plasma mediated b-lactamases. Ceftriaxone in combination with Tazobactam given in one dose immediately after infection shows a significant reduction in bacterial count.


Indications
Lower respiratory tract infections, Nosocomial infections, and surgical prophylaxis
Meningitis, Skin and soft tissue infection like cellulitis. Chronic suppurative bacterial Otitis media, Bone & Joint infections, Sexually transmitted disease (gonorrhea, syphilis), Urinary tract infections (complicated by underlying urological abnormalities).
Composition
Each Vial contains:
 

Ceftriaxone
1000 mg

Tazobactam
125 mg

Dosage
The usual daily dose is 1-2 gm given once a day. Total daily dose should not exceed 4gms.
Pediatric Patients: Recommended total daily dose (in terms of ceftriaxone) 50 to 75 mg / kg given once in a day (or in equally divided doses twice a day). The total daily dose not to exceed 1gm.
Side Effects
GI effects 2 to 3%, cutaneous reactions 1-3%, hematologicals 1-2% Miscellaneous 1.5 to 3%. Rarely, acute anaphylaxis to any of the drug may occur in susceptible individuals.
Precautions
Pregnancy: not advisable for the use
Nursing Mother: caution to exercise.
Pediatric Use: Not to be recommended to hyper bilirubinemic neonates, especially premature.
Presentation
TAZOCEF 1.125 is available as a strip of 10 tablets